Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation

被引:0
|
作者
He, Jianming [1 ]
Qiu, Lugui [2 ]
Schmerold, Luke [3 ]
Potluri, Ravi [3 ]
Li, Lin [4 ]
Hu, Peter [5 ]
Nemat, Sepideh [6 ]
Smugar, Steven S. [7 ]
Appiani, Carlos [8 ]
Mehra, Maneesha [9 ]
Richarz, Ute [10 ]
机构
[1] Janssen, Raritan, NJ USA
[2] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[3] Smart Analyst, New York, NY USA
[4] Xian Janssen Pharmaceut Ltd, Beijing, Peoples R China
[5] Janssen R&D, Raritan, NJ USA
[6] Janssen R&D, High Wycombe, Bucks, England
[7] Janssen R&D, Titusville, NJ USA
[8] Janssen R&D, Spring House, PA USA
[9] Janssen Global Serv, Raritan, NJ USA
[10] Janssen Global Serv, Zug, Switzerland
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词
Multiple myeloma; multiple myeloma-specific survival; multiple-myeloma specific survival;
D O I
10.1016/j.clml.2019.09.380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SP-054
引用
收藏
页码:E229 / E229
页数:1
相关论文
共 50 条
  • [1] EARLY AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cavallo, F.
    Spencer, A.
    Gay, F.
    Hajek, R.
    Petrucci, M. T.
    Ben Yehuda, D.
    Carella, A. M.
    Vallone, L. M.
    Oliva, S.
    Petro, D.
    Crippa, C.
    Siniscalchi, A.
    Gilestro, M.
    Pour, L.
    Maracci, L.
    Pescosta, N.
    Liberati, M.
    Magarotto, V.
    Scudla, V.
    Benevolo, G.
    Pulini, S.
    Caravita, T.
    Hardan, I.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 520 - 520
  • [2] Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study Treatment pattern and outcomes in patients with multiple myeloma
    He, Jianming
    Schmerold, Luke
    Van Rampelbergh, Rian
    Qiu, Lugui
    Potluri, Ravi
    Dasgupta, Anandaroop
    Li, Lin
    Li, Yunan
    Hu, Peter
    Nemat, Sepideh
    Smugar, Steven S.
    Zeltzer, Paul
    Appiani, Carlos
    Li, Qing
    Mehra, Maneesha
    Richarz, Ute
    ADVANCES IN THERAPY, 2021, 38 (01) : 640 - 659
  • [3] Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational StudyTreatment pattern and outcomes in patients with multiple myeloma
    Jianming He
    Luke Schmerold
    Rian Van Rampelbergh
    Lugui Qiu
    Ravi Potluri
    Anandaroop Dasgupta
    Lin Li
    Yunan Li
    Peter Hu
    Sepideh Nemat
    Steven S. Smugar
    Paul Zeltzer
    Carlos Appiani
    Qing Li
    Maneesha Mehra
    Ute Richarz
    Advances in Therapy, 2021, 38 : 640 - 659
  • [4] Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma
    King, Justin
    Fiala, Mark A.
    Goldsmith, Scott R.
    Stockerl-Goldstein, Keith E.
    Schroeder, Mark A.
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya M.
    BLOOD, 2019, 134
  • [5] Advances in maintenance strategy in newly diagnosed multiple myeloma patients eligible for autologous transplantation
    Wahab, Ahsan
    Rafae, Abdul
    Faisal, Muhammad Salman
    Mushtaq, Kamran
    Ehsan, Hamid
    Khakwani, Maria
    Ashraf, Afia
    Rehan, Tayyab
    Ahmed, Zahoor
    Shah, Zunairah
    Khan, Aslam
    Anwer, Faiz
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (12) : 1333 - 1347
  • [6] Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
    Victoria Mateos, M.
    San-Miguel, Jesus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 113 - 119
  • [7] Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
    M. Victoria Mateos
    Jesús San-Miguel
    Current Hematologic Malignancy Reports, 2011, 6 : 113 - 119
  • [8] A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation
    Girnius, Saulius K.
    Lee, Saem
    Kambhampati, Suman
    Rose, Michal G.
    Mohiuddin, Abid
    Houranieh, Antoun
    Zimelman, Abraham
    Grady, Terrence
    Mehta, Paulette
    Behler, Caroline
    Hayes, Teresa G.
    Efebera, Yvonne A.
    Prabhala, Rao H.
    Han, Andrew
    Yellapragada, Sarvari V.
    Klein, Catherine E.
    Roodman, Garson D.
    Lichtenstein, Alan
    Munshi, Nikhil C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 36 - 43
  • [9] Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation
    Cillo, Lorenzo
    Dalla Palma, Anna Benedetta
    Ricci, Stefania
    Pedrazzoni, Mario
    Scita, Matteo
    Bernardi, Matia
    Sammarelli, Gabriella
    Pelagatti, Laura
    Giuliani, Nicola
    EJHAEM, 2024, 5 (04): : 892 - 895
  • [10] Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma
    Bove, Virginia
    Garrido, David
    Riva, Eloisa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (03) : 295 - 302